Antimicrobial Dialkylresorcins from Marine-Derived Microorganisms: Insights into Their Mode of Action and Putative Ecological Relevance

Abstract

Zobellia galactanivorans has been reported as a seaweed-associated or marine-derived species with largely unknown secondary metabolites. The combination of bioinformatic analysis and MS- and bioactivity guided separation led to the isolation of a new antibiotically active dialkylresorcin from the marine bacterium Z. galactanivorans. The antibiotic profile of the new dialkylresorcin zobelliphol (1) was investigated and compared with related and naturally occurring dialkyresorcins (i.e., stemphol (2) and 4-butyl-3,5-dihydroxybenzoic acid (3)) from the marine-derived fungus Stemphylium globuliferum. Bacterial reporter strain assays provided insights into the mode of action of this antibiotic compound class. We identified an interference with bacterial DNA biosynthesis for the dialkylresorcin derivative 1. In addition, the putative biosynthetic gene cluster corresponding to production of 1 was identified and a biosynthetic hypothesis was deduced.

Key words

Zobellia galactanivorans - antibiotics - dialkylresorcins - marine bacteria - biosynthesis

• References

• 1 World Health Organization. Antimicrobial resistance: global report on surveillance 2014. Available at: http://www.who.int/drugresistance/documents/surveillancereport/en Accessed January 1, 2017
• 2 Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov 2015; 14: 111-129
• 3 Schöner TA, Kresovic D, Bode HB. Biosynthesis and function of bacterial dialkylresorcinol compounds. Appl Microbiol Biotechnol 2015; 99: 8323-8328
• 4 Schöner TA, Fuchs SW, Reinhold-Hurek B, Bode HB. Identification and biosynthesis of a novel xanthomonadin-dialkylresorcinol-hybrid from Azoarcus sp. BH72. PLoS One 2014; 9: e90922
• 5 Brameyer S, Kresovic D, Bode HB, Heermann R. Dialkylresorcinols as bacterial signaling molecules. Proc Natl Acad Sci 2015; 112: 572-577
• 6 Harms H, Poehlein A, Thürmer A, König GM, Schäberle TF. Draft genome sequence of Zobellia sp. strain OII3, isolated from the coastal zone of the Baltic Sea. Genome Announc 2017; 5: e00737-17
• 7 Barbeyron T, LʼHaridon S, Corre E, Kloareg B, Potin P. Zobellia galactanovorans gen. nov., sp. nov., a marine species of Flavobacteriaceae isolated from a red alga, and classification of [Cytophaga] uliginosa (ZoBell and Upham 1944) Reichenbach 1989 as Zobellia uliginosa gen. nov., comb. nov. Int J Syst Evol Microbiol 2001; 51: 985-997
• 8 Blin K, Medema MH, Kottmann R, Lee SY, Weber T. The antiSMASH database, a comprehensive database of microbial secondary metabolite biosynthetic gene clusters. Nucleic Acids Res 2017; 45: D555-D559
• 9 Pohanka A, Levenfors J, Broberg A. Antimicrobial dialkylresorcinols from Pseudomonas sp. Ki19. J Nat Prod 2006; 69: 654-657
• 10 Kato S, Shindo K, Kawai H, Matsuoka M, Mochizuki J. Studies on free radical scavenging substances from microorganisms. III. Isolation and structural elucidation of a novel free radical scavenger, resorstatin. J Antibiot (Tokyo) 1993; 46: 1024-1026
• 11 Ji S, Lee JY, Schrör J, Mazumder A, Jang DM, Chateauvieux S, Schnekenburger M, Hong CR, Christov C, Kang HJ, Lee Y, Han BW, Kim KW, Shin HY, Dicato M, Cerella C, König GM, Orlikova B, Diederich M. The dialkyl resorcinol stemphol disrupts calcium homeostasis to trigger programmed immunogenic necrosis in cancer. Cancer Lett 2018; 416: 109-123
• 12 Marumo S, Hattori H, Katayama M. Stemphol from Pleospora herbarum as a self-inhibitor. Agric Biol Chem 1985; 49: 1521-1522
• 13 Li J. Preparation of phenol derivatives useful in the treatment of immune disease and inflammation. PCT Int. Appl., Patent WO 2015010666 A2 20150129, 2015
• 14 Kanda N, Ishizaki N, Inoue N, Oshima M, Handa A. DB-2073, a new alkylresorcinol antibiotic. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) 1975; 28: 935-942
• 15 Onishi HR, Pelak BA, Gerckens LS, Silver LL, Kahan FM, Chen MH, Patchett AA, Galloway SM, Hyland SA, Anderson MS, Raetz CR. Antibacterial agents that inhibit lipid A biosynthesis. Science 1996; 274: 980-982
• 16 Urban A, Eckermann S, Fast B, Metzger S. Novel whole-cell antibiotic biosensors for compound discovery. Appl Environ Microbiol 2007; 73: 6436-6443
• 17 McBride MJ, Xie G, Martens EC, Lapidus A, Henrissat B, Rhodes RG, Goltsman E, Wang W, Xu J, Hunnicutt DW, Staroscik AM, Hoover TR, Cheng YQ, Stein JL. Novel features of the polysaccharide-digesting gliding bacterium Flavobacterium johnsoniae as revealed by genome sequence analysis. Appl Environ Microbiol 2009; 75: 6864-6875
• 18 Fuchs SW, Bozhüyük KAJ, Kresovic D, Grundmann F, Dill V, Brachmann AO, Waterfield NR, Bode HB. Formation of 1,3-cyclohexanediones and resorcinols catalyzed by a widely occuring ketosynthase. Angew Chem Int Ed 2013; 52: 4108-4112
• 19 Schäberle TF. Biosynthesis of α-pyrones. Beilstein J Org Chem 2016; 12: 571-588
• 20 Imai S, Fujioka K, Furihata K, Fudo R, Yamanaka S, Seto H. Studies on cell growth stimulating substances of low molecular weight. Part 3. Resorcinin, a mammalian cell growth stimulating substance produced by Cytophaga johnsonae . J Antibiot (Tokyo) 1993; 46: 1319-1322
• 21 Fogg AH, Lodge RM. The mode of antibacterial action of phenols in relation to drug-fastness. Trans Faraday Soc 1945; 41: 359-365
• 22 Kaufmann GF, Park J, Janda KD. Bacterial quorum sensing: a new target for anti-infective immunotherapy. Expert Opin Biol Ther 2008; 8: 719-724
• 23 Barbeyron T, Thomas F, Barbe V, Teeling H, Schenowitz C, Dossat C, Goesmann A, Leblanc C, Oliver Glöckner F, Czjzek M, Amann R, Michel G. Habitat and taxon as driving forces of carbohydrate catabolism in marine heterotrophic bacteria: example of the model algae-associated bacterium Zobellia galactanivorans DsijT. Environ Microbiol 2016; 18: 4610-4627
• 24 Schäberle TF, Lohr F, Schmitz A, König GM. Antibiotics from myxobacteria. Nat Prod Rep 2014; 31: 953-972
• 25 Korp J, Vela Gurovic MS, Nett M. Antibiotics from predatory bacteria. Beilstein J Org Chem 2016; 12: 594-607